View the SEMAAP-14 registration information details.
Back to drug list
ItemsDrug Registration information
ID140
No140
Brand NameSEMAAP-14
IngredientsSEMAGLUTIDE 14 MG
Dosage FormTABLET
Primary PackagingBOTTLE AND BLISTERPACK
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 10, 30'S/BOTTLE, BOX OF 1 X 10'S AND 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF TYPE 2 DIABETES MELLITUS IN ADULTS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TABLET
Note
License OwnerASIA PHARMACEUTICAL (LAOS) CO.,LTD
ManufacturerASIA PHARMACEUTICAL (LAOS) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No11 L 1247/24
FDD Registration Date19/11/2024
Expiry Date18/11/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA